The cannabis industry is evolving, moving from a previously illicit market to a more mainstream status, though it still operates within a regulatory and financial gray area. Companies like the Biopharmaceutical Research Company (BRC) and Cresco Labs are leading this change by navigating federal restrictions and scaling up operations. Despite challenges such as state-specific regulations and banking constraints, the industry anticipates substantial growth, driven by increasing legalization and consumer acceptance. Innovations in cannabis products and formulations are also propelling the market forward.

Read more →